Robert Michel

Track

Insider profile

Currently holds a position at Daxor Corp

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 27% 68% 82%
Transactions
11 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer Daxor Corp Sept. 28, 2018 -
Chief Financial Officer, Secretary Asta Funding Inc Feb. 20, 2009 - March 9, 2016
Robert Michel's trades of Daxor Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Daxor Corp (DXR)
Transaction date
Purchase
Price
81.54
Quantity 86,601 -43.8%
Value US$4,501,364
US Daxor Corp (DXR)
Transaction date
Purchase
Price
274.27
Quantity 99,514 -37.5%
Value US$694,641
US Daxor Corp (DXR)
Transaction date
Purchase
Price
483.25
Quantity 58,398 +33.8%
Value US$1,976,707
US Daxor Corp (DXR)
Transaction date
Purchase
Price
7.75
Quantity 120 +1.2%
Value US$930
US Daxor Corp (DXR)
Transaction date
Purchase
Price
7.75
Quantity 180 +1.8%
Value US$1,395
US Daxor Corp (DXR)
Transaction date
Purchase
Price
7.94
Quantity 500 +5.1%
Value US$3,970
US Daxor Corp (DXR)
Transaction date
Purchase
Price
9.02
Quantity 500 +6.9%
Value US$4,510
US Daxor Corp (DXR)
Transaction date
Purchase
Price
10.00
Quantity 1,000 +16.0%
Value US$10,000
US Daxor Corp (DXR)
Transaction date
Purchase
Price
10.25
Quantity 1,000 +30.8%
Value US$10,250
US Daxor Corp (DXR)
Transaction date
Purchase
Price
13.02
Quantity 750 +30.0%
Value US$9,765
US Daxor Corp (DXR)
Transaction date
Purchase
Price
7.42
Quantity 2,500 +inf%
Value US$18,550
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-31 2026-03-31
US Daxor Corp (DXR)
B Purchase
86,601 -43.8%
81.54
US$4,501,364 		86,601 -43.8% 81.54 US$4,501,364
2025-03-11 2025-03-10
US Daxor Corp (DXR)
B Purchase
99,514 -37.5%
274.27
US$694,641 		99,514 -37.5% 274.27 US$694,641
2024-03-27 2024-03-27
US Daxor Corp (DXR)
B Purchase
58,398 +33.8%
483.25
US$1,976,707 		58,398 +33.8% 483.25 US$1,976,707
2023-12-06 2023-12-06
US Daxor Corp (DXR)
B Purchase
120 +1.2%
7.75
US$930 		120 +1.2% 7.75 US$930
2023-12-01 2023-12-01
US Daxor Corp (DXR)
B Purchase
180 +1.8%
7.75
US$1,395 		180 +1.8% 7.75 US$1,395
2023-11-27 2023-11-24
US Daxor Corp (DXR)
B Purchase
500 +5.1%
7.94
US$3,970 		500 +5.1% 7.94 US$3,970
2023-10-16 2023-10-13
US Daxor Corp (DXR)
B Purchase
500 +6.9%
9.02
US$4,510 		500 +6.9% 9.02 US$4,510
2022-11-18 2022-11-18
US Daxor Corp (DXR)
B Purchase
1,000 +16.0%
10.00
US$10,000 		1,000 +16.0% 10.00 US$10,000
2021-04-19 2021-04-19
US Daxor Corp (DXR)
B Purchase
1,000 +30.8%
10.25
US$10,250 		1,000 +30.8% 10.25 US$10,250
2019-03-22 2019-03-22
US Daxor Corp (DXR)
B Purchase
750 +30.0%
13.02
US$9,765 		750 +30.0% 13.02 US$9,765
2018-11-08 2018-11-07
US Daxor Corp (DXR)
B Purchase
2,500 +inf%
7.42
US$18,550 		2,500 +inf% 7.42 US$18,550